Page last updated: 2024-10-30

vitamin k 3 and Muscular Dystrophy, Duchenne

vitamin k 3 has been researched along with Muscular Dystrophy, Duchenne in 1 studies

Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.

Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SJ1
Kim, HS1

Other Studies

1 other study available for vitamin k 3 and Muscular Dystrophy, Duchenne

ArticleYear
Deregulation of Nrf2/ARE signaling pathway causes susceptibility of dystrophin-deficient myotubes to menadione-induced oxidative stress.
    Experimental cell research, 2018, 03-15, Volume: 364, Issue:2

    Topics: Antioxidant Response Elements; Cell Survival; Dystrophin; Humans; Muscle Fibers, Skeletal; Muscular

2018